Abstract
In this article possibilities of use new anticonvulsant gabapentin (Meditan®) in clinical practice are summed up at set of diseases, as central and peripheral nervous system from a position of demonstrative medicine and last references of the European Federation of Neurologic Societies (EFNS), the British National institute of health and clinical qualification (NICE), the American Academy of Neurology (AAN) and separate leading associations and communities.
References
1. Маликова Л.А. Влияние леветирацетама на содержание медиаторных аминокислот в структурах мозга крыс при аудиогенном
эпилептиформном припадке / Л.А. Маликова, И.Б. Федотова, П.М. Клодт // Психофармакол. Биол. Наркол. - 2008. - Т. 8, № 3-4. - С. 2448-
2452.
2. Кукушкин М.Л. Неврогенная (невропатическая) боль / М.Л. Кукушкин // Лекарственный вестник. - 2006. - № 6. - C. 61-64.
3. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs I / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1252-1260.
4. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs II / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1261-1273.
5. A Randomized Study of the Effects of Single-dose Gabapentin versus Placebo on Postoperative Pain and Morphine Consumption after Mastectomy /
J. Dirks, B.B. Fredensborg, D. Christensen [et al.] // Anesthesiology. - 2002. - Vol. 97. - P. 560 - 564.
6. Coetzer R. Postherpetic neuralgia / R. Coetzer // S. Afr. Pharm. J. - 2011. - P. 78. - P. 36-39.
7. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition / R.N. Harden, A.L. Oaklander, A.W. Burton, [et al.] //
Pain Medicine. - 2013. - P. 50.
8. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
/ R. Chou, A. Qaseem, V. Snow, [et al.] // Ann. Intern. Med. - 2007. - Vol. 147. - P. 478-491.
9. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision / N. Attal, G. Cruccu, R. Baron, [et al.] // European Journal of
Neurology. - 2010. - Vol. 17. - P. 1113-1123.
10. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force / S. Evers, J. Afra, A. Frese, [et al.] // European Journal of
Neurology. - 2009. - Vol. 16. - P. 968-981.
11. Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of
Neurology / T.A. Zesiewicz, R.J. Elble, E.D. Louis [et al.] // Neurology. - 2011. - Vol. 77. - P. 1752-1755.
12. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for
Psychopharmacology / D.S. Baldwin, I.M. Anderson, D.J. Nutt, [et al.] // Psychopharm. Journal of Psychopharmacology. - 2005. - Vol. 19. - P. 567-596.
13. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of
Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation / V. Bril, J. England, G.M. Franklin
[et al.] // Neurology. - 2011. - Vol. 76. - P. 1758-1765.
14. FDA approves Horizant to treat restless legs syndrome / FDA NEWS, 07.04.2011// http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/
ucm250188.htm.
15. Gabapentin premedication: assessment of preoperative anxiolysis and postoperative patient satisfaction / M. Tirault, L. Foucan, B. Debaene [et al.]
// Acta Anaesth. Belg. - 2010. - Vol. 61. - P. 203-209.
эпилептиформном припадке / Л.А. Маликова, И.Б. Федотова, П.М. Клодт // Психофармакол. Биол. Наркол. - 2008. - Т. 8, № 3-4. - С. 2448-
2452.
2. Кукушкин М.Л. Неврогенная (невропатическая) боль / М.Л. Кукушкин // Лекарственный вестник. - 2006. - № 6. - C. 61-64.
3. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs I / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1252-1260.
4. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs II / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1261-1273.
5. A Randomized Study of the Effects of Single-dose Gabapentin versus Placebo on Postoperative Pain and Morphine Consumption after Mastectomy /
J. Dirks, B.B. Fredensborg, D. Christensen [et al.] // Anesthesiology. - 2002. - Vol. 97. - P. 560 - 564.
6. Coetzer R. Postherpetic neuralgia / R. Coetzer // S. Afr. Pharm. J. - 2011. - P. 78. - P. 36-39.
7. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition / R.N. Harden, A.L. Oaklander, A.W. Burton, [et al.] //
Pain Medicine. - 2013. - P. 50.
8. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
/ R. Chou, A. Qaseem, V. Snow, [et al.] // Ann. Intern. Med. - 2007. - Vol. 147. - P. 478-491.
9. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision / N. Attal, G. Cruccu, R. Baron, [et al.] // European Journal of
Neurology. - 2010. - Vol. 17. - P. 1113-1123.
10. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force / S. Evers, J. Afra, A. Frese, [et al.] // European Journal of
Neurology. - 2009. - Vol. 16. - P. 968-981.
11. Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of
Neurology / T.A. Zesiewicz, R.J. Elble, E.D. Louis [et al.] // Neurology. - 2011. - Vol. 77. - P. 1752-1755.
12. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for
Psychopharmacology / D.S. Baldwin, I.M. Anderson, D.J. Nutt, [et al.] // Psychopharm. Journal of Psychopharmacology. - 2005. - Vol. 19. - P. 567-596.
13. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of
Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation / V. Bril, J. England, G.M. Franklin
[et al.] // Neurology. - 2011. - Vol. 76. - P. 1758-1765.
14. FDA approves Horizant to treat restless legs syndrome / FDA NEWS, 07.04.2011// http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/
ucm250188.htm.
15. Gabapentin premedication: assessment of preoperative anxiolysis and postoperative patient satisfaction / M. Tirault, L. Foucan, B. Debaene [et al.]
// Acta Anaesth. Belg. - 2010. - Vol. 61. - P. 203-209.
Downloads
Download data is not yet available.